Key result
Smooth muscle contractile protein mutations linked to thoracic aortic aneurysms via contractile cytoskeleton disruption.
Why the study?
The organisation of the smooth muscle contractile cytoskeleton is less well understood than that of striated muscle, and the mechanisms by which related mutations lead to disease remain incompletely characterized.
This review provides a comprehensive overview of the smooth muscle contractile cytoskeleton, emphasizing its unique regulatory mechanisms and the role of MYH11 mutations in vascular disease.
Highlights foundational gaps in vascular smooth muscle cytoskeleton organization; leaves open how specific actin mutations drive clinical disease,.
Smooth muscle cells are widespread in the human body, found in a range of tissues from the vasculature to the gut, airways, bladder and so on. They can be found as isolated cells or organised into syncytia (groups of cells). The organisation of the contractile cytoskeleton (smooth muscle actin and myosin filaments) is less well understood than that of striated (cardiac and skeletal) muscle. This review aims to explore what is known, the potential effects of mutations in smooth muscle actin, myosin and tropomyosin and how they lead to disease, and to highlight what we have still to learn about the smooth muscle contractile cytoskeleton.
No takes yet. Share an insight, caveat, or question.
Carrington et al. (2026) conducted a review in Smooth muscle diseases. Mutations in smooth muscle contractile proteins, including actin, myosin, and tropomyosin, disrupt the contractile cytoskeleton and are strongly linked to diseases such as thoracic aortic aneurysms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: